InVivo Therapeutics Holdings CEO Richard Toselli's 2021 pay jumps 30% to $1.1M
InVivo Therapeutics Holdings reports 2021 executive compensation
By ExecPay News
Published: August 18, 2022
InVivo Therapeutics Holdings reported fiscal year 2021 executive compensation information on August 18, 2022.
In 2021, two executives at InVivo Therapeutics Holdings received on average a compensation package of $889K, a 28% increase compared to previous year.
Average pay of disclosed executives at InVivo Therapeutics Holdings
Richard Toselli, Chief Executive Officer, received $1.1M in total, which increased by 30% compared to 2020. 48% of Toselli's compensation, or $517K, was in salary. Toselli also received $409K in bonus, $139K in option awards, as well as $15K in other compensation.
Richard Christopher, Chief Financial Officer, received a compensation package of $698K, which increased by 25% compared to previous year. 51% of the compensation package, or $355K, was in salary.
Related executives
You may also like
Source: SEC filing on August 18, 2022.